HILLEVAX INC (HLVX) Forecast, Price Target & Analyst Ratings

NASDAQ:HLVXUS43157M1027

Current stock price

2.09 USD
-0.01 (-0.48%)
At close:
2.1 USD
+0.01 (+0.48%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HILLEVAX INC (HLVX).

Forecast Snapshot

Consensus Price Target

Price Target
$2.04
-2.39% Downside

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q3 / 2025
EPS Estimate
-$0.12
Revenue Estimate

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$2.04
Upside
-2.39%
From current price of $2.09 to mean target of $2.04, Based on 6 analyst forecasts
Low
$2.02
Median
$2.04
High
$2.10

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for HLVX. The average price target is 2.04 USD. This implies a price decrease of -2.39% is expected in the next year compared to the current price of 2.09.

Analyst Ratings & History

Current Analyst Ratings

HLVX Current Analyst RatingHLVX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

HLVX Historical Analyst RatingsHLVX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
HLVX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about HLVX.
In the previous month the buy percentage consensus was at a similar level.
HLVX was analyzed by 6 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-03-31HC Wainwright & Co.Reiterate Neutral -> Neutral
2024-08-12HC Wainwright & Co.Reiterate Neutral -> Neutral
2024-07-09Leerink PartnersDowngrade Outperform -> Market Perform
2024-07-09StifelDowngrade Buy -> Hold
2024-07-09HC Wainwright & Co.Downgrade Buy -> Neutral
2024-07-08GuggenheimDowngrade Buy -> Neutral
2024-07-08JP MorganDowngrade Overweight -> Neutral
2024-05-15JP MorganMaintains Overweight -> Overweight
2024-05-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-21HC Wainwright & Co.Reiterate Buy -> Buy
2023-12-13HC Wainwright & Co.Initiate Buy
2023-11-15GuggenheimMaintains Buy -> Buy
2023-11-10StifelMaintains Buy -> Buy
2023-05-16JP MorganMaintains Overweight -> Overweight
2022-05-24GuggenheimInitiate Buy
2022-05-24SVB LeerinkInitiate Outperform
2022-05-24StifelInitiate Buy
2022-05-24JP MorganInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q3 / 2025
EPS Estimate
-$0.12
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
76.46%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
11.11%

Next Earnings Summary

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
HLVX revenue by date.HLVX revenue by date.
N/AN/AN/AN/AN/A
102.26%
N/A
39.52%
N/A
29.16%
N/A
8.68%
EBITDA
YoY % growth
HLVX ebitda by date.HLVX ebitda by date.
-630K-1.3M
-106.35%
-53.43M
-4,010.00%
-65.11M
-21.86%
-131.189M
-101.49%
-103.761M
20.91%
N/A
-12.07%
N/A
-14.91%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
HLVX ebit by date.HLVX ebit by date.
-630K-1.3M
-106.35%
-53.43M
-4,010.00%
-65.11M
-21.86%
-133.345M
-104.80%
-106.959M
19.79%
N/A
70.56%
N/A
-1.00%
N/A
-1.00%
N/A
41.47%
N/A
72.47%
N/A
204.36%
N/A
201.72%
N/A
24.43%
Operating Margin
HLVX operating margin by date.HLVX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
HLVX eps by date.HLVX eps by date.
N/AN/AN/A-13.10-3.04
76.79%
-3.00
1.32%
N/A
83.34%
N/A
6.12%
N/A
6.52%
N/A
-153.49%
N/A
-1.83%
N/A
77.48%
N/A
256.00%
N/A
146.15%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.12
76.46%
-0.12
82.00%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/A
EBIT
Q2Q % growth
-7.912M
70.01%
-7.991M
29.78%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HLVX Yearly Revenue VS EstimatesHLVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 20M 40M 60M
HLVX Yearly EPS VS EstimatesHLVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -5 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.84%
EPS Next 5 Year
10.16%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

HILLEVAX INC / HLVX Forecast FAQ

What do analysts expect the price target to be for HILLEVAX INC (HLVX)?

6 analysts have analysed HLVX and the average price target is 2.04 USD. This implies a price decrease of -2.39% is expected in the next year compared to the current price of 2.09.

Can you provide the consensus estimates for HILLEVAX INC next earnings?

The consensus EPS estimate for the next earnings of HILLEVAX INC (HLVX) is -0.12 USD and the consensus revenue estimate is 0 USD.